Cytalux (Pofalacianine)
- Medicine Name: Cytalux
- Generic Name: Pofalacianine
- Dosage Form & Strength: Injection: 3.2 mg/1.6 mL (2 mg/mL) of pafolacianine in a single-dose vial
- Manufactured By: On Target Laboratories, Inc.
Medical Uses
Cytalux is an FDA approved optical imaging agent used as an adjunct for intraoperative identification of:
- Malignant lesions in adult individuals with ovarian cancer.
- Malignant and non-malignant pulmonary lesions in adult individuals with known or suspected cancer in the lung.
Recommended Dosage: Perform pregnancy test in women of reproductive age and veify the absence of pregnancy before the use of Cytalux injection. Folate, folic acid, or folate containing supplements must be discontinued 48 hours prior to administration of Cytalux. Consider the use of antihistamines or/and anti-nausea medicine for prophylaxis against infusion-related reactions.
Adult Patients with Ovarian Cancer: The recommended dose is a single intravenous infusion of 0.025 mg/kg diluted in 250 mL of 5% dextrose injection, given over 60 minutes using a dedicated infusion line, 1 to 9 hour before surgery.
Adult Patients with Known or Suspected Cancer in the Lung: The recommended dose is a single intravenous infusion of 0.025 mg/kg diluted in 250 mL of 5% dextrose injection, given over 60 minutes using a dedicated infusion line, 1 to 24 hour before surgery.
Warning & Precautions
- Some adverse reactions including vomiting, nausea, abdominal pain, dyspepsia, flushing, chest discomfort, hypersensitivity, and elevation in blood pressure may occur in patients receiving Cytalux. Reactions may occur within 15 minutes of the start of the infusion. Treatment with antihistamines/anti-nausea medicine may be used.
- If the respective patient develops an infusion reaction during the use of Cytalux 3.2 mg injection infusion, interrupt the infusion and treat with antihistamines or/and anti-nausea medicine as required, on behalf of clinical decision.Finish the infusion within hours hours of the initiation of initial administration
- Errors may emerge with the use of Pofalacianine during intraoperative fluorescence imaging to detect ovarian cancer and lesions in the lung, including false negatives/positives. Non-fluorescing tissue in the surgical field does not rule out the existence of ovarian cancer or lesions in the lung. Fluorescence may be noticed in normal tissues including lungs, bowel, kidneys, and lymph nodes as well as in inflamed tissues.
- Depending on its mechanism of action, Pofalacianine may be responsible for causing fetal harm if administered to a pregnant woman. Females of reproductive age/potential of the potential risk to a fetus should use effective contraception method. Verify pregnancy status prior to initiating this treatment.
- There are no findings on the existence of pafolacianine in the human milk, the effects on the breastfed infant, or the effects on the production of milk. The developmental and health benefits of breastfeeding needs to be considered along with the mother’s clinical requirement for this medicine and any potential side effects on the breastfed infant from pafolacianine or from the underlying maternal condition.
- Consideration of the incorrect diluent to prepare the Pofalacianine infusion solution can cause the aggregation of pafolacianine; aggregation may induce infusion reactions, such as vomiting, nausea, abdominal pain or rash. Consider only 5 percent Dextrose Injection to prepare this infusion solution. Avoid using other diluents.
Documentation & Availability
What documents are required to import CYTALUX to India?
CYTALUX (pofalacianine) injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is CYTALUX available in India?
CYTALUX (pofalacianine injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is facilitator providing input
- On availability of Cytalux in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
CYTALUX can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of CYTALUX (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Cytalux 3.2 mg injection price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the CYTALUX (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Cytalux®?
Pofalacianine is Generic Name for the trade name drug Cytalux®.
What is the Manufacturer Name of Cytalux®?
Cytalux® is manufactured by On Target Laboratories, Inc.
Is Cytalux® approved by the FDA?
Yes, Cytalux® is approved by the FDA. Date of first/initial approval: November 29, 2021.
Where can I get Cytalux® at the best price in India?
To get the best cytalux price in India, kindly contact S S Healthcare (a WHO GDP & ISO 9001 : 2008 certified company). For Cytalux, a valid medical prescription is required from your treating physician.
What is the dosage and form of Cytalux® supplied?
Cytalux® is supplied as Injection: 3.2 mg/1.6 mL (2 mg/mL) of pafolacianine in a single-dose vial for intravenous administration.
What are the most common side effects with Cytalux®?
The most common side effects with Cytalux® include: vomiting, nausea, abdominal pain, flushing, other infusion-related reactions, hypersensitivity, dyspepsia, elevation in blood pressure, and chest discomfort.
How much does Cytalux® cost in India?
The cytalux cost in India is less and can vary. In order to procure this medication authentically, you can Call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Cytalux®?
Store frozen between -25° to -15°C (-13° to 5°F). Store the medicine in original carton to protect from light.
Is it safe to buy Cytalux® (pofalacianine injection) online from India?
Yes, you can buy pafolacianine injection online at best price from the S S Healthcare if Cytalux® has not been approved or is not available in your country.
What are the Highlights of prescribing information for Cytalux®?
Click Here to download full Cytalux prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
